ABA-101 in Participants With Progressive Multiple Sclerosis
Clinical trial NCT06566261 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06566261
- Sponsor
- Abata Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-11
- Primary completion
- 2026-02-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.